Key Takeaways
- After a tough year for Walgreens investors in 2024, shares may have appeared poised to start 2025 on strong note after the company's first-quarter results topped expectations.
- However, analysts have remained cautious, mostly keeping "hold" or "sell" ratings on the pharmacy retailer's stock.
- A lawsuit filed late last week by the Department of Justice sent shares lower Tuesday, adding to the company's challenges.
After a tough year for Walgreens (WBA) investors in 2024, shares may have appeared poised to start 2025 on strong note after the company's 澳洲幸运5开奖号码历史查询:first-quarter results topped 澳洲幸运5开奖号码历史查询:expectations.
However, even before a new lawsuit from the Department of Justice 澳洲幸运5开奖号码历史查询:sent shares sharply lower T🀅uesday, analysts remained uncertain about the stock.
Among the eight analysts covering Walgreens tracked by Visible Alpha, four issued 澳洲幸运5开奖号码历史查询:"hold" ratings for the stock, three rated it "sell," and just one gave it a "buy" rating, with an average 澳洲幸运5开奖号码历史查询:price target of $10.81, just below the level Walgr꧑eens shares closed at Tuesday after tumbling over 9% to $11.37.
Jefferies and Deutsche Bank analysts kept "hold" ratings and voiced caution earlier this month in the wake of the company's better-than-expected results. Jefferies analysts said that while the results were encouraging, they "don't see it as an 'all clear' just yet," adding they "want to see more positive datapoints" before projecting a larger turnaround.
The analysts warned that despite the company's cost-cutting efforts like 澳洲幸运5开奖号码历史查询:clo🔯sing hundreds of "underpeꦆrforming" storesಞ, the company's retail pharmacy business is likely to "remain challenged."
The new suit from the DOJ adds a layer of regulatory risk to Walgreens' already-challenged retail environment, as its CEO acknowledged in its earnings call earlier this month that some strategies like locking up products did not work as well as expected.